BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Machielsen AJHM, Iqbal N, Kimman ML, Sahnan K, Adegbola SO, Kleijnen J, Vaizey CJ, Grossi U, Tozer PJ, Breukink SO. The development of a cryptoglandular Anal Fistula Core Outcome Set (AFCOS): an international Delphi study protocol. United European Gastroenterol J 2020;8:220-6. [PMID: 32213065 DOI: 10.1177/2050640620907570] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Adegbola SO, Sahnan K, Tozer P, Warusavitarne J. Emerging Data on Fistula Laser Closure (FiLaC) for the Treatment of Perianal Fistulas; Patient Selection and Outcomes. Clin Exp Gastroenterol 2021;14:467-75. [PMID: 34908858 DOI: 10.2147/CEG.S269464] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sluckin TC, Gispen WH, Jongenotter J, Hazen SJA, Smeets S, van der Bilt JDW, Smeenk RM, Schouten R. Treatment of cryptoglandular fistulas with the fistula tract laser closure (FiLaC™) method in comparison with standard methods: first results of a multicenter retrospective comparative study in the Netherlands. Tech Coloproctol 2022. [PMID: 35749023 DOI: 10.1007/s10151-022-02644-7] [Reference Citation Analysis]
3 Vollebregt PF, Vander Mijnsbrugge GJ, Molenaar CBH, Felt-Bersma RJF. Efficacy of Permacol injection for perianal fistulas in a tertiary referral population: poor outcome in patients with complex fistulas. Colorectal Dis 2021;23:2119-26. [PMID: 33955138 DOI: 10.1111/codi.15696] [Reference Citation Analysis]
4 Dekker L, Zimmerman DDE, Smeenk RM, Schouten R, Han-Geurts IJM. Management of cryptoglandular fistula-in-ano among gastrointestinal surgeons in the Netherlands.Tech Coloproctol. 2021;25:709-719. [PMID: 33860363 DOI: 10.1007/s10151-021-02446-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang Y, Chen Y, Niu M, Li Y, Zhang J, Zhang L, Wu F, Chen Q, Yu H, Tian J. Establishing a core outcome set for neurogenic bladder trials: study protocol for a scoping review and Delphi surveys. Trials 2022;23:485. [PMID: 35698096 DOI: 10.1186/s13063-022-06419-1] [Reference Citation Analysis]
6 Machielsen AJHM, Iqbal N, Kimman ML, Sahnan K, Adegbola SO, Kane G, Woodcock R, Kleijnen J, Grossi U, Breukink SO, Tozer PJ. Heterogeneity in outcome selection, definition and measurement in studies assessing the treatment of cryptoglandular anal fistula: findings from a systematic review. Tech Coloproctol 2021;25:761-830. [PMID: 33963945 DOI: 10.1007/s10151-021-02452-5] [Reference Citation Analysis]